Pharmacology Corner

Pharmacology education for healthcare professionals

  • Animations
  • Psychopharmacology
  • PowerPoints
  • About
Menu
  • Animations
  • Psychopharmacology
  • PowerPoints
  • About

Tag: Cymbalta

Differences between tricyclic antidepressants and SNRIs mechanism of action

Images, mindmaps and tables integration of both TCAs and SNRIs MOA. Muscarinic, histaminic and alpha 1 receptors blockade determines TCAs

Duloxetine (Cymbalta, Yentreve): a serotonin-norepinephrine reuptake inhibitor for major depression. Australian prescriber review

From Australian Prescriber: Duloxetine Cymbalta (Eli Lilly) 30 mg and 60 mg capsules Approved indication: major depression Australian Medicines Handbook section 18.1.2 Duloxetine is a new antidepressant which selectively inhibits serotonin and noradrenaline reuptake. It also weakly inhibits dopamine uptake. (See details of its mechanism of action)

Pharmacology Corner

Pharmacology education for healthcare professionals

All rights reserved

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos